Search Results - "Rutten‐van Mölken, Maureen"

Tiotropium versus Salmeterol for the Prevention of Exacerbations of COPD by Vogelmeier, Claus, Hederer, Bettina, Glaab, Thomas, Schmidt, Hendrik, Rutten-van Mölken, Maureen P.M.H, Beeh, Kai M, Rabe, Klaus F, Fabbri, Leonardo M

“…An important goal in the treatment of COPD is the prevention of exacerbations. In this trial, the investigators found that treatment with tiotropium, as…”
Get full text

Real-life compliance and persistence among users of subcutaneous and sublingual allergen immunotherapy by Kiel, Menno A., MD, MSc, Röder, Esther, MD, PhD, Gerth van Wijk, Roy, MD, PhD, Al, Maiwenn J., PhD, Hop, Wim C.J., PhD, Rutten-van Mölken, Maureen P.M.H., PhD

“…Background Subcutaneous allergen immunotherapy (SCIT) and sublingual allergen immunotherapy (SLIT) are safe and effective treatments of allergic rhinitis, but…”
Get full text

The disease burden of multimorbidity and its interaction with educational level by Chen, Yi Hsuan, Karimi, Milad, Rutten-van Mölken, Maureen P M H

“…Policies to adequately respond to the rise in multimorbidity have top-priority. To understand the actual burden of multimorbidity, this study aimed to: 1)…”
Get full text

Clinical and economic impact of non-adherence in COPD: A systematic review by van Boven, Job F.M, Chavannes, Niels H, van der Molen, Thys, Rutten-van Mölken, Maureen P.M.H, Postma, Maarten J, Vegter, Stefan

“…Summary Background Medication for Chronic Obstructive Pulmonary Disease (COPD) has shown to substantially reduce symptoms and slow progression of disease…”
Get full text

COVID-19 Contact Tracing Apps: Predicted Uptake in the Netherlands Based on a Discrete Choice Experiment by Jonker, Marcel, de Bekker-Grob, Esther, Veldwijk, Jorien, Goossens, Lucas, Bour, Sterre, Rutten-Van Mölken, Maureen

“…Smartphone-based contact tracing apps can contribute to reducing COVID-19 transmission rates and thereby support countries emerging from lockdowns as…”
Get full text

TECH-VER: A Verification Checklist to Reduce Errors in Models and Improve Their Credibility by Büyükkaramikli, Nasuh C., Rutten-van Mölken, Maureen P. M. H., Severens, Johan L., Al, Maiwenn

“…Background In health economic literature, checklists or best practice recommendations on model validation/credibility always declare verification of the…”
Get full text

Current and Future Incidence and Costs of Osteoporosis-Related Fractures in The Netherlands: Combining Claims Data with BMD Measurements by Lötters, Freek J. B., van den Bergh, Joop P., de Vries, Frank, Rutten-van Mölken, Maureen P. M. H.

“…This study aims to estimate the incidence and costs of osteoporosis-related fractures in The Netherlands in 2010 and project them to 2030. The incidence and…”
Get full text

Prospective cohort study for assessment of integrated care with a triple aim approach: hospital at home as use case by Herranz, Carme, González-Colom, Rubèn, Baltaxe, Erik, Seijas, Nuria, Asenjo, Maria, Hoedemakers, Maaike, Nicolas, David, Coloma, Emmanuel, Fernandez, Joaquim, Vela, Emili, Cano, Isaac, Mölken, Maureen Rutten-van, Roca, Josep, Hernandez, Carme

“…Background Applicability of comprehensive assessment of integrated care services in real world settings is an unmet need. To this end, a Triple Aim evaluation…”
Get full text

How to Address Uncertainty in Health Economic Discrete-Event Simulation Models: An Illustration for Chronic Obstructive Pulmonary Disease by Corro Ramos, Isaac, Hoogendoorn, Martine, Rutten-van Mölken, Maureen P. M. H.

“…Background. Evaluation of personalized treatment options requires health economic models that include multiple patient characteristics. Patient-level…”
Get full text

Cost-Effectiveness of the Angiotensin Receptor Neprilysin Inhibitor Sacubitril/Valsartan for Patients with Chronic Heart Failure and Reduced Ejection Fraction in the Netherlands: A Country Adaptation Analysis Under the Former and Current Dutch Pharmacoeconomic Guidelines by Ramos, Isaac Corro, PhD, Versteegh, Matthijs M., PhD, de Boer, Rudolf A., MD, PhD, Koenders, Jolanda M.A., MSc, Linssen, Gerard C.M., MD, PhD, Meeder, Joan G., MD, PhD, Rutten-van Mölken, Maureen P.M.H., PhD

“…Abstract Objectives To describe the adaptation of a global health economic model to determine whether treatment with the angiotensin receptor neprilysin…”
Get full text

The risk of overestimating cost savings from hospital-at-home schemes: A literature review by Goossens, Lucas M.A., Vemer, Pepijn, Rutten-van Mölken, Maureen P.M.H.

“…The concept of hospital-at-home means that home treatment is provided to patients who would otherwise have been treated in the hospital. This may lead to lower…”
Get full text

Early cost-utility analysis of tissue-engineered heart valves compared to bioprostheses in the aortic position in elderly patients by Huygens, Simone A., Ramos, Isaac Corro, Bouten, Carlijn V. C., Kluin, Jolanda, Chiu, Shih Ting, Grunkemeier, Gary L., Takkenberg, Johanna J. M., Mölken, Maureen P. M. H. Rutten-van

“…Objectives Aortic valve disease is the most frequent indication for heart valve replacement with the highest prevalence in elderly. Tissue-engineered heart…”
Get full text

How Can a Bundled Payment Model Incentivize the Transition from Single-Disease Management to Person-Centred and Integrated Care for Chronic Diseases in the Netherlands? by Bour, Sterre S, Raaijmakers, Lena H A, Bischoff, Erik W M A, Goossens, Lucas M A, Rutten-van Mölken, Maureen P M H

“…To stimulate the integration of chronic care across disciplines, the Netherlands has implemented single-disease management programmes (SDMPs) in primary care…”
Get full text

Improving inhaler adherence in patients with chronic obstructive pulmonary disease: a cost-effectiveness analysis by van Boven, Job Fm, Tommelein, Eline, Boussery, Koen, Mehuys, Els, Vegter, Stefan, Brusselle, Guy Go, Rutten-van Mölken, Maureen Pmh, Postma, Maarten J

“…The PHARMACOP-intervention significantly improved medication adherence and inhalation technique for patients with COPD compared with usual care. This study…”
Get full text

A five-year model to assess the early cost-effectiveness of new diagnostic tests in the early diagnosis of rheumatoid arthritis by Buisman, Leander R, Luime, Jolanda J, Oppe, Mark, Hazes, Johanna M W, Rutten-van Mölken, Maureen P M H

“…There is a lack of information about the sensitivity, specificity and costs new diagnostic tests should have to improve early diagnosis of rheumatoid arthritis…”
Get full text

Development of a Conceptual Model of Disease Progression for Use in Economic Modeling of Chronic Obstructive Pulmonary Disease by Tabberer, Maggie, Gonzalez-McQuire, Sebastian, Muellerova, Hana, Briggs, Andrew H., Rutten-van Mölken, Maureen P. M. H., Chambers, Mike, Lomas, David A.

“…Background. To develop and validate a new conceptual model (CM) of chronic obstructive pulmonary disease (COPD) for use in disease progression and economic…”
Get full text

Systematic Review and Quality Appraisal of Cost-Effectiveness Analyses of Pharmacologic Maintenance Treatment for Chronic Obstructive Pulmonary Disease: Methodological Considerations and Recommendations by van der Schans, Simon, Goossens, Lucas M. A., Boland, Melinde R. S., Kocks, Janwillem W. H., Postma, Maarten J., van Boven, Job F. M., Rutten-van Mölken, Maureen P. M. H.

“…Background Worldwide, chronic obstructive pulmonary disease (COPD) is a highly prevalent chronic lung disease with considerable clinical and socioeconomic…”
Get full text

Statistical Modeling of Disease Progression for Chronic Obstructive Pulmonary Disease Using Data from the ECLIPSE Study by Exuzides, Alex, Colby, Chris, Briggs, Andrew H., Lomas, David A., Rutten-van Mölken, Maureen P. M. H., Tabberer, Maggie, Chambers, Mike, Muellerova, Hana, Locantore, Nicholas, Risebrough, Nancy A., Ismaila, Afisi S., Gonzalez-McQuire, Sebastian

“…Background. To develop statistical models predicting disease progression and outcomes in chronic obstructive pulmonary disease (COPD), using data from ECLIPSE,…”
Get full text

Effects of Achieving Target Measures in Rheumatoid Arthritis on Functional Status, Quality of Life, and Resource Utilization: Analysis of Clinical Practice Data by Alemao, Evo, Joo, Seongjung, Kawabata, Hugh, Al, Maiwenn J., Allison, Paul D., Rutten‐van Mölken, Maureen P. M. H., Frits, Michelle L., Iannaccone, Christine K., Shadick, Nancy A., Weinblatt, Michael E.

“…Objective To evaluate associations between achieving guideline‐recommended targets of disease activity, defined by the Disease Activity Score in 28 joints…”
Get full text

Mix and match. A simulation study on the impact of mixed-treatment comparison methods on health-economic outcomes by Vemer, Pepijn, Al, Maiwenn J, Oppe, Mark, Rutten-van Mölken, Maureen P M H

“…Decision-analytic cost-effectiveness (CE) models combine many parameters, often obtained after meta-analysis. We compared different methods of mixed-treatment…”
Get full text